The Early High Risk Period for Patients With Heart Failure

The Early High Risk Period for Patients With Incident Heart Failure: A Population Based Study

Many people with heart failure either die or are admitted to the hospital in the first few months after the condition is diagnosed. The reasons for this are currently unclear- but may be due to worsening heart failure or other medical conditions such as angina, heart attack or sudden electrical problems of the heart. The investigators propose to recruit and follow-up 450 people, with a new diagnosis of heart failure for a minimum of six months in a multi-centre observational study at two hospital sites: The Hillingdon (Uxbridge) and The Conquest (Hastings) hospitals. The total study duration will be two years. People will be recruited after a diagnosis of heart failure is made and the study will assess reasons for death or admission to hospital and the psychological impact of the condition on both patients and their carers. This is an observational study and no change will be made to patients' conventional treatment.

Hypotheses:

  1. The high mortality and hospitalisation rate in the early period after diagnosis of heart failure is related to progressive pump failure; or
  2. The high mortality in the early period after the diagnosis of heart failure is related to co-morbid events- principally major coronary events such as myocardial infarction or acute coronary syndrome.

This research should help to identify ways of improving the outlook for people with newly diagnosed heart failure. The analysis of the data generated by this study will be supervised by a statistician. Clinical and demographic data will be described using mean + standard deviation, for continuous variables, and absolute numbers and percentages for categorical variables. Group differences will be examined by t-tests for continuous variables and Chi-square (x2) test for categorical variables. Survival will be reported in terms of Kaplan-Meier curves with differences analysed by Cox proportional hazards.

Study Overview

Status

Unknown

Study Type

Observational

Enrollment

450

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Hastings, United Kingdom
        • The Conquest Hospital
      • London, United Kingdom, UB8 3NN
        • Hillingdon Hospital, Pield Heath Road

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Clinical diagnosis of heart failure

Exclusion Criteria:

  • Under age of 18 years
  • Unable to give consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Martin R Cowie, MD MRCP MSc, Imperial College London and Royal Brompton NHS Trust
  • Principal Investigator: Paresh A Mehta, MBChB MRCP, Imperial College and Royal Brompton Trust
  • Principal Investigator: Simon W Dubrey, MD MRCP, The Hillingdon Hospitals NHS Foundation Trust
  • Principal Investigator: Hugh F McIntyre, MD FRCP, East Sussex Hospitals NHS Trust
  • Principal Investigator: David M Walker, MD FRCP, East Sussex Hospitals NHS Trust

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2004

Study Completion

January 1, 2006

Study Registration Dates

First Submitted

August 3, 2005

First Submitted That Met QC Criteria

August 3, 2005

First Posted (ESTIMATE)

August 5, 2005

Study Record Updates

Last Update Posted (ESTIMATE)

February 13, 2006

Last Update Submitted That Met QC Criteria

February 9, 2006

Last Verified

February 1, 2006

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2003EP005B
  • PG/03/097

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe